In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Pictured: Breast tumor treated with paclitaxel
In the Lab
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Pictured: Hans-Guido Wendel
Profile
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.
Pictured: Gabriela Chiosis
Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug

A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
An illustration
Feature
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
Pictured: Milind Rajadhyaksha, Snehal Patel & Ricardo Toledo-Crow
Out of the Lab and into the World: The Endoscopic Laser Scalpel

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.
Pictured: Craig Thompson
Perspective
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
Pictured: Scott W. Lowe
Biologist Scott Lowe Joins Memorial Sloan Kettering

Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center.
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
MSK doctors
Memorial Sloan Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan Kettering and New York University has shown that <i>TET2</i> loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.